Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins.
Identifieur interne : 000B41 ( Main/Exploration ); précédent : 000B40; suivant : 000B42Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins.
Auteurs : G. Patuzzo [Italie] ; E. Tinazzi [Italie] ; M. Micheletti [Italie] ; A. Puccetti [Italie] ; C. Lunardi [Italie]Source :
- European annals of allergy and clinical immunology [ 1764-1489 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte, Agammaglobulinémie (), Agammaglobulinémie (diagnostic), Agammaglobulinémie (immunologie), Facteurs immunologiques (administration et posologie), Facteurs immunologiques (sang), Humains, Immunoglobuline G (administration et posologie), Immunoglobuline G (sang), Indice de gravité médicale, Lymphangiectasie intestinale (), Lymphangiectasie intestinale (diagnostic), Lymphangiectasie intestinale (immunologie), Lymphoedème (), Lymphoedème (diagnostic), Lymphoedème (immunologie), Mâle, Perfusions sous-cutanées, Régime pauvre en graisses, Résultat thérapeutique, Triglycéride (administration et posologie).
- MESH :
- administration et posologie : Facteurs immunologiques, Immunoglobuline G, Triglycéride.
- diagnostic : Agammaglobulinémie, Lymphangiectasie intestinale, Lymphoedème.
- immunologie : Agammaglobulinémie, Lymphangiectasie intestinale, Lymphoedème.
- sang : Facteurs immunologiques, Immunoglobuline G.
- Adulte, Agammaglobulinémie, Humains, Indice de gravité médicale, Lymphangiectasie intestinale, Lymphoedème, Mâle, Perfusions sous-cutanées, Régime pauvre en graisses, Résultat thérapeutique.
English descriptors
- KwdEn :
- Adult, Agammaglobulinemia (diagnosis), Agammaglobulinemia (immunology), Agammaglobulinemia (therapy), Diet, Fat-Restricted, Humans, Immunoglobulin G (administration & dosage), Immunoglobulin G (blood), Immunologic Factors (administration & dosage), Immunologic Factors (blood), Infusions, Subcutaneous, Lymphangiectasis, Intestinal (complications), Lymphangiectasis, Intestinal (diagnosis), Lymphangiectasis, Intestinal (immunology), Lymphangiectasis, Intestinal (therapy), Lymphedema (complications), Lymphedema (diagnosis), Lymphedema (immunology), Lymphedema (therapy), Male, Severity of Illness Index, Treatment Outcome, Triglycerides (administration & dosage).
- MESH :
- chemical , administration & dosage : Immunoglobulin G, Immunologic Factors, Triglycerides.
- chemical , blood : Immunoglobulin G, Immunologic Factors.
- complications : Lymphangiectasis, Intestinal, Lymphedema.
- diagnosis : Agammaglobulinemia, Lymphangiectasis, Intestinal, Lymphedema.
- immunology : Agammaglobulinemia, Lymphangiectasis, Intestinal, Lymphedema.
- therapy : Agammaglobulinemia, Lymphangiectasis, Intestinal, Lymphedema.
- Adult, Diet, Fat-Restricted, Humans, Infusions, Subcutaneous, Male, Severity of Illness Index, Treatment Outcome.
Abstract
Primary intestinal lymphangiectasia (PIL) is rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage; it is responsible for protein losing enteropathy leading to lymphopenia, hypoalbuminemia and hypogammaglobulinemia. A low-fat diet associated with medium-chain triglyceride supplementation is the cornerstone of PIL management. The administration of intravenous immunoglobulins does not always lead to satisfactory plasma levels and therefore the replacement therapy with immunoglobulins is controversial. We describe here the case of a patient with PIL and severe hypogammaglobulinemia treated with immunoglobulins. The striking aspect of this case is the clinical and serological benefit obtained with the subcutaneous compared to the intravenous immunoglobulins administration.
PubMed: 26934740
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000972
- to stream PubMed, to step Curation: 000972
- to stream PubMed, to step Checkpoint: 000972
- to stream Ncbi, to step Merge: 007F60
- to stream Ncbi, to step Curation: 007F60
- to stream Ncbi, to step Checkpoint: 007F60
- to stream Main, to step Merge: 000B42
- to stream Main, to step Curation: 000B41
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins.</title>
<author><name sortKey="Patuzzo, G" sort="Patuzzo, G" uniqKey="Patuzzo G" first="G" last="Patuzzo">G. Patuzzo</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Immunology and Allergy Unit Department of Medicine University of Verona 37134 Verona, Italy. E-mail: jeps.pz@gmail.com Phone: +39 045 812 4401 Fax: +39 045 802 7473.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinical Immunology and Allergy Unit Department of Medicine University of Verona 37134 Verona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tinazzi, E" sort="Tinazzi, E" uniqKey="Tinazzi E" first="E" last="Tinazzi">E. Tinazzi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Verona, Verona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medicine, University of Verona, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Micheletti, M" sort="Micheletti, M" uniqKey="Micheletti M" first="M" last="Micheletti">M. Micheletti</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Verona, Verona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medicine, University of Verona, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Puccetti, A" sort="Puccetti, A" uniqKey="Puccetti A" first="A" last="Puccetti">A. Puccetti</name>
<affiliation wicri:level="3"><nlm:affiliation>Immunology Area, Pediatric Hospital Bambino Gesù, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Immunology Area, Pediatric Hospital Bambino Gesù, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lunardi, C" sort="Lunardi, C" uniqKey="Lunardi C" first="C" last="Lunardi">C. Lunardi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Verona, Verona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medicine, University of Verona, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26934740</idno>
<idno type="pmid">26934740</idno>
<idno type="wicri:Area/PubMed/Corpus">000972</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000972</idno>
<idno type="wicri:Area/PubMed/Curation">000972</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000972</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000972</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000972</idno>
<idno type="wicri:Area/Ncbi/Merge">007F60</idno>
<idno type="wicri:Area/Ncbi/Curation">007F60</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007F60</idno>
<idno type="wicri:doubleKey">1764-1489:2016:Patuzzo G:secondary:hypogammaglobulinemia:in</idno>
<idno type="wicri:Area/Main/Merge">000B42</idno>
<idno type="wicri:Area/Main/Curation">000B41</idno>
<idno type="wicri:Area/Main/Exploration">000B41</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins.</title>
<author><name sortKey="Patuzzo, G" sort="Patuzzo, G" uniqKey="Patuzzo G" first="G" last="Patuzzo">G. Patuzzo</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Immunology and Allergy Unit Department of Medicine University of Verona 37134 Verona, Italy. E-mail: jeps.pz@gmail.com Phone: +39 045 812 4401 Fax: +39 045 802 7473.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinical Immunology and Allergy Unit Department of Medicine University of Verona 37134 Verona</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tinazzi, E" sort="Tinazzi, E" uniqKey="Tinazzi E" first="E" last="Tinazzi">E. Tinazzi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Verona, Verona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medicine, University of Verona, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Micheletti, M" sort="Micheletti, M" uniqKey="Micheletti M" first="M" last="Micheletti">M. Micheletti</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Verona, Verona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medicine, University of Verona, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Puccetti, A" sort="Puccetti, A" uniqKey="Puccetti A" first="A" last="Puccetti">A. Puccetti</name>
<affiliation wicri:level="3"><nlm:affiliation>Immunology Area, Pediatric Hospital Bambino Gesù, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Immunology Area, Pediatric Hospital Bambino Gesù, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lunardi, C" sort="Lunardi, C" uniqKey="Lunardi C" first="C" last="Lunardi">C. Lunardi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Verona, Verona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medicine, University of Verona, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">European annals of allergy and clinical immunology</title>
<idno type="ISSN">1764-1489</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Agammaglobulinemia (diagnosis)</term>
<term>Agammaglobulinemia (immunology)</term>
<term>Agammaglobulinemia (therapy)</term>
<term>Diet, Fat-Restricted</term>
<term>Humans</term>
<term>Immunoglobulin G (administration & dosage)</term>
<term>Immunoglobulin G (blood)</term>
<term>Immunologic Factors (administration & dosage)</term>
<term>Immunologic Factors (blood)</term>
<term>Infusions, Subcutaneous</term>
<term>Lymphangiectasis, Intestinal (complications)</term>
<term>Lymphangiectasis, Intestinal (diagnosis)</term>
<term>Lymphangiectasis, Intestinal (immunology)</term>
<term>Lymphangiectasis, Intestinal (therapy)</term>
<term>Lymphedema (complications)</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (immunology)</term>
<term>Lymphedema (therapy)</term>
<term>Male</term>
<term>Severity of Illness Index</term>
<term>Treatment Outcome</term>
<term>Triglycerides (administration & dosage)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Agammaglobulinémie ()</term>
<term>Agammaglobulinémie (diagnostic)</term>
<term>Agammaglobulinémie (immunologie)</term>
<term>Facteurs immunologiques (administration et posologie)</term>
<term>Facteurs immunologiques (sang)</term>
<term>Humains</term>
<term>Immunoglobuline G (administration et posologie)</term>
<term>Immunoglobuline G (sang)</term>
<term>Indice de gravité médicale</term>
<term>Lymphangiectasie intestinale ()</term>
<term>Lymphangiectasie intestinale (diagnostic)</term>
<term>Lymphangiectasie intestinale (immunologie)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (immunologie)</term>
<term>Mâle</term>
<term>Perfusions sous-cutanées</term>
<term>Régime pauvre en graisses</term>
<term>Résultat thérapeutique</term>
<term>Triglycéride (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Immunoglobulin G</term>
<term>Immunologic Factors</term>
<term>Triglycerides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Immunoglobulin G</term>
<term>Immunologic Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Facteurs immunologiques</term>
<term>Immunoglobuline G</term>
<term>Triglycéride</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphangiectasis, Intestinal</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Agammaglobulinemia</term>
<term>Lymphangiectasis, Intestinal</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Agammaglobulinémie</term>
<term>Lymphangiectasie intestinale</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Agammaglobulinémie</term>
<term>Lymphangiectasie intestinale</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Agammaglobulinemia</term>
<term>Lymphangiectasis, Intestinal</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Facteurs immunologiques</term>
<term>Immunoglobuline G</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Agammaglobulinemia</term>
<term>Lymphangiectasis, Intestinal</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Diet, Fat-Restricted</term>
<term>Humans</term>
<term>Infusions, Subcutaneous</term>
<term>Male</term>
<term>Severity of Illness Index</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Agammaglobulinémie</term>
<term>Humains</term>
<term>Indice de gravité médicale</term>
<term>Lymphangiectasie intestinale</term>
<term>Lymphoedème</term>
<term>Mâle</term>
<term>Perfusions sous-cutanées</term>
<term>Régime pauvre en graisses</term>
<term>Résultat thérapeutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Primary intestinal lymphangiectasia (PIL) is rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage; it is responsible for protein losing enteropathy leading to lymphopenia, hypoalbuminemia and hypogammaglobulinemia. A low-fat diet associated with medium-chain triglyceride supplementation is the cornerstone of PIL management. The administration of intravenous immunoglobulins does not always lead to satisfactory plasma levels and therefore the replacement therapy with immunoglobulins is controversial. We describe here the case of a patient with PIL and severe hypogammaglobulinemia treated with immunoglobulins. The striking aspect of this case is the clinical and serological benefit obtained with the subcutaneous compared to the intravenous immunoglobulins administration.</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
<region><li>Latium</li>
</region>
<settlement><li>Rome</li>
</settlement>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Patuzzo, G" sort="Patuzzo, G" uniqKey="Patuzzo G" first="G" last="Patuzzo">G. Patuzzo</name>
</noRegion>
<name sortKey="Lunardi, C" sort="Lunardi, C" uniqKey="Lunardi C" first="C" last="Lunardi">C. Lunardi</name>
<name sortKey="Micheletti, M" sort="Micheletti, M" uniqKey="Micheletti M" first="M" last="Micheletti">M. Micheletti</name>
<name sortKey="Puccetti, A" sort="Puccetti, A" uniqKey="Puccetti A" first="A" last="Puccetti">A. Puccetti</name>
<name sortKey="Tinazzi, E" sort="Tinazzi, E" uniqKey="Tinazzi E" first="E" last="Tinazzi">E. Tinazzi</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26934740 |texte= Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26934740" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |